ECJ PHARMACEUTICAL SUBSIDIARIES LIABILITY CASE
March 1st, 2006
BY KEITH NUTHALL
EUROPEAN Union pharmaceutical manufacturers may have difficulty avoiding defective product claims through time limitation rules if they argue delivering a medicine to a wholly-owned subsidiary means releasing it onto the market. This advice from European Court of Justice (ECJ) came in a case involving Sonofi Pasteur MSD Ltd. It is being sued by Declan O'Byrne over alleged vaccine damages, but the company's predecessor Aventis Pasteur SA, of France, delivered the medicine to its UK subsidiary Aventis Pasteur MSD Ltd more than 10 years before the ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.